Werkgroep Cardiologische centra Nederland English

MK021 (Klaar)

A 24-Week, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Anacetrapib When Added to Ongoing Statin Therapy With or Without Other Lipid Modifying Medication(s) in Patients with Hypercholesterolemia or Low HDL-C

Middel
Anacetrapib
Populatie
preventie (cholesterol)
Fase
III
Jaar aanvang
2012

Contactpersoon

dr. J. Schaap (Cardioloog)
Breda, Amphia Ziekenhuis